ClinicalTrials.gov
ClinicalTrials.gov Menu

3rd Party LMP1/2-Specific Cytotoxic T Lymphocytes for EBV-Associated Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02057445
Recruitment Status : Completed
First Posted : February 7, 2014
Last Update Posted : December 22, 2017
Sponsor:
Collaborators:
Children's Research Institute
Baylor College of Medicine
M.D. Anderson Cancer Center
University of Michigan
University of Utah
City of Hope Medical Center
Ohio University
Johns Hopkins University
Information provided by (Responsible Party):
Mitchell Cairo, New York Medical College

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2016
  Actual Study Completion Date : December 2017